Displaying 1 - 1 of 1
| Active Ingredient | TIZANIDINE |
| Therapeutic Class | NEUROMUSCULAR BLOCKING AGENTS |
| Indications | Spasticity associated with multiple sclerosis and cerebrovascular or spinal cord disorders. |
| Caution | Drowsiness, muscle weakness, dry mouth, fatigue, insomnia, G.I. disturbances, dizziness. |
| Dose Range | Adult: 2-4mg three times daily . Maximum dose is 36mg daily. Safety has not been determined in children.See BDS supply protocols pg. 11. |
| Drug Interactions | |
| Pregnancy | Avoid Tizanidine during pregnancy. |
| Breast Feeding | Avoid breastfeeding during Tizanidine therapy. |